Novartis’s Remibrutinib Succeeds In Pivotal CSU Trials With Promise Of Liver Safety

 
• By Ayisha Sharma
drawn outline of a liver on a blue background, post it with smiley face
Liver Toxicities Have Plagued Other BTK Inhibitors For Multiple Sclerosis • Source: Shutterstock

More from Clinical Trials

More from R&D